3.13
price up icon2.62%   0.08
pre-market  Vorhandelsmarkt:  3.21   0.08   +2.56%
loading
Schlusskurs vom Vortag:
$3.05
Offen:
$3.07
24-Stunden-Volumen:
122.05K
Relative Volume:
0.06
Marktkapitalisierung:
$10.09M
Einnahmen:
$12.99M
Nettoeinkommen (Verlust:
$-23.72M
KGV:
-0.0322
EPS:
-97.2514
Netto-Cashflow:
$-23.28M
1W Leistung:
+7.19%
1M Leistung:
-24.94%
6M Leistung:
-96.52%
1J Leistung:
-99.02%
1-Tages-Spanne:
Value
$3.01
$3.17
1-Wochen-Bereich:
Value
$2.89
$3.18
52-Wochen-Spanne:
Value
$2.81
$381.10

Aptevo Therapeutics Inc Stock (APVO) Company Profile

Name
Firmenname
Aptevo Therapeutics Inc
Name
Telefon
206-838-0500
Name
Adresse
2401 4TH AVE., SEATTLE, WA
Name
Mitarbeiter
37
Name
Twitter
@aptevo
Name
Nächster Verdiensttermin
2024-11-12
Name
Neueste SEC-Einreichungen
Name
APVO's Discussions on Twitter

Vergleichen Sie APVO mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
APVO
Aptevo Therapeutics Inc
3.13 9.41M 12.99M -23.72M -23.28M -97.25
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Aptevo Therapeutics Inc Stock (APVO) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2018-11-05 Eingeleitet Ladenburg Thalmann Buy
2017-10-05 Fortgesetzt Piper Jaffray Overweight

Aptevo Therapeutics Inc Aktie (APVO) Neueste Nachrichten

pulisher
05:49 AM

What analysts say about Aptevo Therapeutics Inc. stockFree AI-Backed Trading Signals - Autocar Professional

05:49 AM
pulisher
Jul 22, 2025

Is Aptevo Therapeutics Inc. a good long term investmentHigh-velocity capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Aptevo Therapeutics Inc. Stock Analysis and ForecastSuperior trading gains - Autocar Professional

Jul 21, 2025
pulisher
Jul 19, 2025

What drives Aptevo Therapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 16, 2025

Aptevo Meets Nasdaq $2.5M Equity Requirement - MSN

Jul 16, 2025
pulisher
Jul 16, 2025

What makes Aptevo Therapeutics Inc. stock price move sharplyFree Access to Community - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

Why Aptevo Therapeutics Inc. stock attracts strong analyst attentionFree Elite Traders Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Aptevo Therapeutics Inc. stock performs during market volatility2x 3x 5x Pick Alert - Newser

Jul 15, 2025
pulisher
Jul 11, 2025

10 Best Get Rich Quick Stocks to Buy Now - Insider Monkey

Jul 11, 2025
pulisher
Jul 02, 2025

Aptevo regains Nasdaq compliance following $15.9 million equity raise By Investing.com - Investing.com India

Jul 02, 2025
pulisher
Jul 01, 2025

Aptevo Therapeutics Regains Nasdaq Compliance with Equity Raise - TipRanks

Jul 01, 2025
pulisher
Jul 01, 2025

Aptevo regains Nasdaq compliance following $15.9 million equity raise - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

Aptevo Therapeutics Raises $15.9M to Meet Nasdaq Compliance - TipRanks

Jun 30, 2025
pulisher
Jun 24, 2025

Aptevo Therapeutics' Mysterious 10% Spike: What’s Behind the Surge? - AInvest

Jun 24, 2025
pulisher
Jun 23, 2025

Aptevo (APVO) appoints Baker Tilly as auditor after Moss Adams merger - Stock Titan

Jun 23, 2025
pulisher
Jun 22, 2025

Aptevo Therapeutics Plummets 18%: A Technical & Order-Flow Deep Dive - AInvest

Jun 22, 2025
pulisher
Jun 21, 2025

Benzinga Bulls And Bears: Circle, Sunrun, JetBlue — And Mideast Has Markets Nervous - Benzinga

Jun 21, 2025
pulisher
Jun 20, 2025

Top Medical Stocks To Watch Today – June 18th - Defense World

Jun 20, 2025
pulisher
Jun 19, 2025

Aptevo Therapeutics Surges 82% Amid No Fundamental News—What’s Driving the Spike? - AInvest

Jun 19, 2025
pulisher
Jun 18, 2025

Top Small Cap Stocks Worth WatchingJune 18th - MarketBeat

Jun 18, 2025
pulisher
Jun 18, 2025

Crude Oil Moves Higher; US Weekly Jobless Claims Decline - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics raises $8 million in registered direct offering - Investing.com Australia

Jun 18, 2025
pulisher
Jun 18, 2025

Dow Surges 150 Points; Korn Ferry Earnings Top Views - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Secures $8M Through Direct Offering - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics announces $8M at-the-market equity offering with warrants; shares more than double - MSN

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics raises $8 million in registered direct offering By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 18, 2025

Why Is Micro-Cap Aptevo Stock Trading Higher On Wednesday?Aptevo Therapeutics (NASDAQ:APVO) - Benzinga

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules | APVO Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

An early stage 85% remissions rate in AML drives Aptevo’s stock surge - BioWorld MedTech

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Announces $8 Million Offering Priced At-the-Market Under Nasdaq Rules - ACCESS Newswire

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Secures $8M Funding: Biotech Company Accelerates Cancer Drug Development Pipeline - Stock Titan

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics stock soars after impressive AML treatment results - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics stock soars after impressive AML treatment results By Investing.com - Investing.com Canada

Jun 18, 2025
pulisher
Jun 18, 2025

Why did Aptevo Therapeutics Shares Skyrocket in Premarket Trading Today? - Tokenist

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics Skyrockets on Game-Changing AML Drug News - RagingBull

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo reports 85% remission rate in frontline AML trial By Investing.com - Investing.com Nigeria

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Shows Promising Results in RAINIER Tr - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Says Its Mipletamig Therapy Achieves 85% Remission Rate in Leukemia Patients; Shares Soar Pre-Bell - MarketScreener

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics (APVO) Shows Promising Results in AML Trial - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo Therapeutics announces new clinical data from RAINIER trial - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Aptevo announces clinical data from ongoing Phase 1b/2 RAINIER trial - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Breakthrough AML Drug Achieves 85% Remission Rate: New Hope for Previously Untreatable Patients - Stock Titan

Jun 18, 2025
pulisher
Jun 17, 2025

Aptevo Therapeutics Signs Equity Purchase Agreement - TipRanks

Jun 17, 2025

Finanzdaten der Aptevo Therapeutics Inc-Aktie (APVO)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):